Apolipoprotein B levels and related factors in a rural white South African community--the CORIS study. Coronary Risk

K Steyn1, J E Rossouw, M J Weight

  • 1Chronic Diseases of Lifestyle Programme, Medical Research Council, Parowvallel, W. Cape.

Insights

Apolipoprotein B (apoB) may predict coronary heart disease (CHD) risk better than cholesterol. However, its routine use for screening is discouraged due to cost and measurement variability.

Area of Science:

  • Cardiovascular disease research
  • Lipid metabolism and atherosclerosis
  • Public health and epidemiology

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Accurate risk assessment is crucial for effective prevention strategies.
  • Apolipoprotein B (apoB) is a key component of atherogenic lipoproteins.

Purpose of the Study:

  • To evaluate apolipoprotein B (apoB) levels as a predictor of coronary heart disease (CHD) risk.
  • To identify other CHD risk factors associated with apoB.
  • To compare apoB with traditional lipid markers for CHD risk stratification.

Main Methods:

  • Cross-sectional analytical study utilizing questionnaires, electrocardiography, anthropometric and blood pressure measurements.
  • Analysis of lipid profiles, including apolipoprotein B (apoB) and total cholesterol (TC).
  • Inclusion of 1,528 white respondents aged 15-68 years from the Coronary Risk Factor Study (CORIS).

Main Results:

  • Men exhibited higher mean apoB levels than women.
  • ApoB and TC classifications for CHD risk showed discordance in 39-41.5% of participants.
  • Higher apoB risk categories correlated with increased prevalence of hypercholesterolemia, hypertension, elevated TC, LDL, triglycerides, BMI, and body fat percentage.
  • Stepwise multiple regression accounted for 84.9% (men) and 85.8% (women) of apoB variation.

Conclusions:

  • Apolipoprotein B (apoB) may offer superior prediction of coronary heart disease (CHD) risk compared to TC or LDL cholesterol.
  • Despite its potential, routine screening use of apoB is not recommended.
  • Factors such as cost, measurement variability, and similar management approaches to TC discourage widespread apoB screening.
Abstract

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...